COMMUNIQUÉS West-GlobeNewswire
-
Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026
29/05/2026 -
Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026
29/05/2026 -
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
29/05/2026 -
Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA
29/05/2026 -
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
29/05/2026 -
Dr. Kamalesh Sets New Benchmarks for Urological Surgery in the UAE: Minimally Invasive, Maximum Results!
29/05/2026 -
Glass House Brands Completes Previously Announced Warrant Redemption
29/05/2026 -
At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research
29/05/2026 -
Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical
29/05/2026 -
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
29/05/2026 -
Mud Wtr Reviews: Is This Mushroom Coffee Alternative Worth Drinking?
29/05/2026 -
Spectral Medical Announces PMA Submission to U.S. FDA for PMX
29/05/2026 -
Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes
29/05/2026 -
PICARD MEDICAL, INC. Issues Letter to Shareholders
29/05/2026 -
Seer Files ITC Complaint Against Nanomics
29/05/2026 -
Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026
29/05/2026 -
Sequana Medical Announces Presentation on Recompensation of Decompensated Cirrhosis Following alfapump® Placement at EASL Congress 2026
29/05/2026 -
Gumitide Gummies Under Investigation: Examining Customer Complaints, Ingredients Claims and Serious Side Effects Risk
29/05/2026 -
MEDIROM Group Reports Q1 2026 Results
29/05/2026
Pages